Probing the structure of human protein disulfide isomerase by chemical cross-linking combined with mass spectrometry

Journal of Proteomics

Volumn 108, Issue , 2014, Pages 1-16

  Peng, Li ^a   Rasmussen, Morten Ib ^a   Chailyan, Anna ^a   Houen, Gunnar ^b   Højrup, Peter ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

BS3; Calnexin; Cross linking; ERp72; Placenta; Protein structure

Indexed keywords

CALNEXIN; CHAPERONE; PROTEIN DISULFIDE ISOMERASE; PLACENTA PROTEIN;

ALKYLATION; ARTICLE; CHEMICAL CROSS LINKING FOLLOWED BY MASS SPECTROMETRY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; OXIDATION REDUCTION STATE; PLACENTA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; ROOM TEMPERATURE; X RAY; CHEMISTRY; FEMALE; ISOLATION AND PURIFICATION; PROCEDURES; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; FEMALE; HUMANS; MASS SPECTROMETRY; PREGNANCY PROTEINS; PROTEIN DISULFIDE-ISOMERASES; PROTEIN STRUCTURE, TERTIARY;

EID: 84901245913     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.04.037     Document Type: Article

References (67)

1. Trincao J., Hamilton M.L., Christensen J., Pearson A.R. Dynamic structural science: recent developments in time-resolved spectroscopy and X-ray crystallography. Biochem Soc Trans 2013, 41(5):1260-1264.
2. Allen J.P., Seng C., Larson C. Structures of proteins and cofactors: X-ray crystallography. Photosynth Res 2009, 102(2-3):231-240.
3. Chayen N.E., Saridakis E. Protein crystallization: from purified protein to diffraction-quality crystal. Nat Methods 2008, 5(2):147-153.
4. Ilari A., Savino C. Protein structure determination by X-ray crystallography. Methods Mol Biol 2008, 452:63-87.
5. Rossmann M.G., Morais M.C., Leiman P.G., Zhang W. Combining X-ray crystallography and electron microscopy. Structure 2005, 13(3):355-362.
6. Pusey M.L., Liu Z.J., Tempel W., Praissman J., Lin D., Wang B.C., et al. Life in the fast lane for protein crystallization and X-ray crystallography. Prog Biophys Mol Biol 2005, 88(3):359-386.
7. Alanen H.I., Salo K.E.H., Pekkala M., Siekkinen H.M., Pirneskoski A., Ruddock L.W. Defining the domain boundaries of the human protein disulfide isomerases. Antioxid Redox Signal 2003, 5(4):367-374.
8. Darby N.J., Creighton T.E. Functional properties of the individual thioredoxin-like domains of protein disulfide isomerase. Biochemistry 1995, 34(37):11725-11735.
9. Freedman R.B., Gane P.J., Hawkins H.C., Hlodan R., McLaughlin S.H., Parry J.W. Experimental and theoretical analyses of the domain architecture of mammalian protein disulphide-isomerase. Biol Chem 1998, 379(3):321-328.
10. Hatahet F., Ruddock L.W. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal 2009, 11(11):2807-2850.
11. Venetianer P., Straub F.B. The enzymic reactivation of reduced ribonuclease. Biochim Biophys Acta 1963, 67:166-168.
12. Frand A.R., Cuozzo J.W., Kaiser C.A. Pathways for protein disulphide bond formation. Trends Cell Biol 2000, 10(5):203-210.
13. Freedman R.B. Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins. Cell 1989, 57(7):1069-1072.
14. Jordan P.A., Gibbins J.M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal 2006, 8(3-4):312-324.
15. Tager M., Kroning H., Thiel U., Ansorge S. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Exp Hematol 1997, 25(7):601-607.
16. Peaper D.R., Cresswell P. Regulation of MHC class I assembly and peptide binding. Annu Rev Cell Dev Biol 2008, 24:343-368.
17. Janiszewski M., Lopes L.R., Carmo A.O., Pedro M.A., Brandes R.P., Santos C.X., Laurindo F.R. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 2005, 280(49):40813-40819.
18. Tian G., Xiang S., Noiva R., Lennarz W.J., Schindelin H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites (vol 124, pg 61, 2006). Cell 2006, 124(5):1085-1088.
19. Wang C., Li W., Ren J.Q., Fang J.Q., Ke H.M., Gong W.M., et al. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal 2013, 19(1):44-53.
20. Kozlov G., Maattanen P., Schrag J.D., Pollock S., Cygler M., Nagar B., et al. Crystal structure of the bb' domains of the protein disulfide isomerase ERp57. Structure 2006, 14(8):1331-1339.
21. Tian G., Kober F.X., Lewandrowski U., Sickmann A., Lennarz W.J., Schindelin H. The catalytic activity of protein-disulfide isomerase requires a conformationally flexible molecule. J Biol Chem 2008, 283(48):33630-33640.
22. Wang C., Yu J., Huo L., Feng W., Wang C.C. Human protein-disulfide isomerase is a redox-regulated chaperone activated by oxidation of domain a'. J Biol Chem 2012, 287(2):1139-1149.
23. Billeter M., Wagner G., Wuthrich K. Solution NMR structure determination of proteins revisited. J Biomol NMR 2008, 42(3):155-158.
24. Bonvin A.M.J.J., Boelens R., Kaptein R. NMR analysis of protein interactions. Curr Opin Chem Biol 2005, 9(5):501-508.
25. Foster M.P., McElroy C.A., Amero C.D. Solution NMR of large molecules and assemblies. Biochemistry 2007, 46(2):331-340.
26. Kay L.E. NMR studies of protein structure and dynamics. J Magn Reson 2005, 173(2):193-207.
27. Neira J.L. NMR as a tool to identify and characterize protein folding intermediates. Arch Biochem Biophys 2013, 531(1-2):90-99.
28. Shapiro Y.E. NMR spectroscopy on domain dynamics in biomacromolecules. Prog Biophys Mol Biol 2013, 112(3):58-117.
29. Shi Y., Wu J. Structural basis of protein-protein interaction studied by NMR. J Struct Funct Genomics 2007, 8(2-3):67-72.
30. Shin J., Lee W., Lee W. Structural proteomics by NMR spectroscopy. Expert Rev Proteomics 2008, 5(4):589-601.
31. Sibille N., Bernado P. Structural characterization of intrinsically disordered proteins by the combined use of NMR and SAXS. Biochem Soc Trans 2012, 40:955-962.
32. Tzakos A.G., Grace C.R.R., Lukavsky P.J., Riek R. NMR techniques for very large proteins and RNAs in solution. Annu Rev Biophys Biomol Struct 2006, 35:319-342.
33. Darby N.J., Penka E., Vincentelli R. The multi-domain structure of protein disulfide isomerase is essential for high catalytic efficiency. J Mol Biol 1998, 276(1):239-247.
34. Dijkstra K., Karvonen P., Pirneskoski A., Koivunen P., Kivirikko K.I., Darby N.J., et al. Assignment of 1H, 13C and 15N resonances of the a' domain of protein disulfide isomerase. J Biomol NMR 1999, 14(2):195-196.
35. Kemmink J., Darby N.J., Dijkstra K., Nilges M., Creighton T.E. Structure determination of the N-terminal thioredoxin-like domain of protein disulfide isomerase using multidimensional heteronuclear 13C/15N NMR spectroscopy. Biochemistry 1996, 35(24):7684-7691.
36. Kemmink J., Darby N.J., Dijkstra K., Scheek R.M., Creighton T.E. Nuclear magnetic resonance characterization of the N-terminal thioredoxin-like domain of protein disulfide isomerase. Protein Sci 1995, 4(12):2587-2593.
37. Kemmink J., Dijkstra K., Mariani M., Scheek R.M., Penka E., Nilges M., et al. The structure in solution of the b domain of protein disulfide isomerase. J Biomol NMR 1999, 13(4):357-368.
38. Nguyen V.D., Wallis K., Howard M.J., Haapalainen A.M., Salo K.E., Saaranen M.J., et al. Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b' domain. J Mol Biol 2008, 383(5):1144-1155.
39. Bernado P., Svergun D.I. Structural analysis of intrinsically disordered proteins by small-angle X-ray scattering. Mol Biosyst 2012, 8(1):151-167.
40. Blanchet C.E., Svergun D.I. Small-angle X-ray scattering on biological macromolecules and nanocomposites in solution. Annu Rev Phys Chem 2013, 64:37-54.
41. Kathuria S.V., Guo L., Graceffa R., Barrea R., Nobrega R.P., Matthews C.R., et al. Minireview: structural insights into early folding events using continuous-flow time-resolved small-angle X-ray scattering. Biopolymers 2011, 95(8):550-558.
42. Mertens H.D.T., Svergun D.I. Structural characterization of proteins and complexes using small-angle X-ray solution scattering. J Struct Biol 2010, 172(1):128-141.
43. Petoukhov M.V., Svergun D.I. Applications of small-angle X-ray scattering to biomacromolecular solutions. Int J Biochem Cell Biol 2013, 45(2):429-437.
44. Li S.J., Hong X.G., Shi Y.Y., Li H., Wang C.C. Annular arrangement and collaborative actions of four domains of protein-disulfide isomerase - A small angle X-ray scattering study in solution. J Biol Chem 2006, 281(10):6581-6588.
45. Olsen D.T., Peng L., Traeholt S.D., Duus K., Hojrup P., Houen G. Purification and characterization of a soluble calnexin from human placenta. Protein Expr Purif 2013, 92(1):105-111.
46. Rasmussen M.I., Refsgaard J.C., Peng L., Houen G., Hojrup P. CrossWork: Software-assisted identification of cross-linked peptides. J Proteomics 2011, 74(10):1871-1883.
47. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234(3):779-815.
48. Hojrup P., Roepstorff P., Houen G. Human placental calreticulin characterization of domain structure and post-translational modifications. Eur J Biochem 2001, 268(9):2558-2565.
49. Chouquet A., Paidassi H., Ling W.L., Frachet P., Houen G., Arlaud G.J., et al. X-ray structure of the human calreticulin globular domain reveals a peptide-binding area and suggests a multi-molecular mechanism. PLoS One 2011, 6(3):e17886.
50. Kozlov G., Azeroual S., Rosenauer A., Maattanen P., Denisov A.Y., Thomas D.Y., et al. Structure of the catalytic a(0)a fragment of the protein disulfide isomerase ERp72. J Mol Biol 2010, 401(4):618-625.
51. Gallina A., Hanley T.M., Mandel R., Trahey M., Broder C.C., Viglianti G.A., et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 2002, 277(52):50579-50588.
52. Ryser H.J., Fluckiger R. Progress in targeting HIV-1 entry. Drug Discov Today 2005, 10(16):1085-1094.
53. Lovat P.E., Corazzari M., Armstrong J.L., Martin S., Pagliarini V., Hill D., et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008, 68(13):5363-5369.
54. Bennett T.A., Edwards B.S., Sklar L.A., Rogelj S. Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes. J Immunol 2000, 164(8):4120-4129.
55. Cho J., Furie B.C., Coughlin S.R., Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008, 118(3):1123-1131.
56. Jasuja R., Furie B., Furie B.C. Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood 2010, 116(22):4665-4674.
57. Jasuja R., Passam F.H., Kennedy D.R., Kim S.H., van Hessem L., Lin L., et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest 2012, 122(6):2104-2113.
58. Reinhardt C., von Bruhl M.L., Manukyan D., Grahl L., Lorenz M., Altmann B., et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008, 118(3):1110-1122.
59. Hoffstrom B.G., Kaplan A., Letso R., Schmid R.S., Turmel G.J., Lo D.C., et al. Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat Chem Biol 2010, 6(12):900-906.
60. Uehara T., Nakamura T., Yao D., Shi Z.Q., Gu Z., Ma Y., et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441(7092):513-517.
61. Walker A.K., Atkin J.D. Mechanisms of neuroprotection by protein disulphide isomerase in amyotrophic lateral sclerosis. Neurol Res Int 2011, 2011:317340.
62. Walker A.K., Farg M.A., Bye C.R., McLean C.A., Horne M.K., Atkin J.D. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain 2010, 133:105-116.
63. Klappa P., Ruddock L.W., Darby N.J., Freedman R.B. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J 1998, 17(4):927-935.
64. Byrne L.J., Sidhu A., Wallis A.K., Ruddock L.W., Freedman R.B., Howard M.J., et al. Mapping of the ligand-binding site on the b' domain of human PDI: interaction with peptide ligands and the X-linker region. Biochem J 2009, 423(2):209-217.
65. Denisov A.Y., Maattanen P., Dabrowski C., Kozlov G., Thomas D.Y., Gehring K. Solution structure of the bb' domains of human protein disulfide isomerase. FEBS J 2009, 276(5):1440-1449.
66. Wang C., Chen S., Wang X., Wang L., Wallis A.K., Freedman R.B., et al. Plasticity of human protein disulfide isomerase: evidence for mobility around the X-linker region and its functional significance. J Biol Chem 2010, 285(35):26788-26797.
67. Pocanschi C.L., Kozlov G., Brockmeier U., Brockmeier A., Williams D.B., Gehring K. Structural and functional relationships between the lectin and arm domains of calreticulin. J Biol Chem 2011, 286(31):27266-27277.